Beijing Strong Biotechnologies,Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Beijing Jiuqiang Biotechnology Co., Ltd. is one of the leading suppliers of clinical in vitro diagnostic products and services in China. Established in 2001, Jiuqiang Biotechnology is a national high-tech enterprise mainly engaged in the research and development, production, and sales of in vitro diagnostic products. It has a series of in vitro diagnostic products that are in sync with international development. The company is located in the capital of China - Beijing, with a registered capital of RMB 588997245. It was successfully listed on the Growth Enterprise Market in 2014, with a stock code of 300406. As one of the leading enterprises in the domestic in vitro diagnostic industry, we are committed to creating the best in vitro diagnostic testing platform. Currently, we have biochemical testing systems, blood coagulation testing systems, blood type testing systems, and pathological examination systems. With years of stable development and improvement accumulation, we have formed a marketing and service network throughout the country. We have always focused on the research and development of in vitro diagnostic product systems and have a first-class product research and development team. Under the leadership of experts, we have established biochemical research and development platforms such as chemical method, enzyme method (including circulating enzyme method), ordinary immune turbidimetry, latex enhanced immune turbidimetry, clone enzyme donor enzyme immunoassay technology (CEDIA), and enzyme enhanced immunoassay technology (EMIT); At the same time, we also have a high-level R&D technical team for full liquid blood coagulation. In 2018, blood group detection products with microcolumn gel method as the core were launched, marking that the top nine biological companies officially entered the field of blood group matching detection. We are a co developer and preparation enterprise of CysC national standard, responsible for two national high-tech research and development plans (863 plan), and the national science and technology support plan project. The company's research and development center is the "Beijing Engineering Laboratory of Biochemical Immunodiagnostic Reagents". To meet the needs of the company's rapid development, we have established an internationally first-class product production environment and production management process, adhering to the principle of "quality first", and providing high-quality clinical testing projects covering clinical biochemistry and blood fields to the market. We can provide diversified clinical diagnostic solutions for different target customers. At the same time, we attach greater importance to the user experience of the terminal, and our technical service team across the country ensures to solve problems for users in the first time and provide comprehensive technical service support. Walking with giants. Since 2013, Top 9 Biotech has successively established strategic cooperation relationships with renowned domestic and foreign enterprises such as Abbott, Roche, Hitachi, Mindray, and Weigao. The "Technology License and Transfer Cooperation Agreement" signed with Abbott has even pioneered the technology export of Chinese IVD enterprises. After more than ten years of significant development, Top 9 Biotech has grown into one of China's leading manufacturers of in vitro diagnostic products and gradually gained a foothold in the international IVD market. "Loyalty, integrity, and passion" is the corporate creed of the Nine Strong Biology. Nowadays, the top nine biological companies have grown into one of the leaders in China's in vitro diagnostic industry, and we are continuously striving to provide higher quality products and services to global users. |
| Headquarter | Beijing |
| Establish Date | 3/29/2001 |
| Listed Code | 300406.SZ |
| Listed Date | 10/30/2014 |
| Chairman | Zou Zuojun. |
| CEO | Liang Hongjun. |
| Website | www.bsbe.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
